Filter
934
Filtered Results: 934
Text search:
pharmaceutical
industry
Featured
Recommendations
65
New Publications
228
Language
Document type
No document type
444
Studies & Reports
217
Guidelines
142
Strategic & Response Plan
54
Manuals
44
Fact sheets
11
Situation Updates
9
Training Material
4
Resource Platforms
3
Brochures
2
Infographics
2
Online Courses
2
Countries / Regions
India
53
Global
46
Kenya
44
Ethiopia
25
South Africa
24
Nepal
18
Nigeria
18
Ghana
16
Sierra Leone
16
Uganda
16
Bangladesh
14
Philippines
12
Zambia
12
Indonesia
11
Ukraine
10
Africa
10
Tanzania
10
Western and Central Europe
10
Syria
9
Zimbabwe
9
Latin America and the Carribbean
9
Namibia
9
Myanmar / Burma
9
Rwanda
8
West and Central Africa
8
Botswana
8
Lesotho
7
Malawi
7
South–East Asia Region
6
Mozambique
5
Cambodia
5
East and Southern Africa
5
Eastern Europe
5
Asia
4
Venezuela
4
Liberia
4
Eswatini/ Swaziland
4
Thailand
3
Middle East and North Africa
3
Papua New Guinea
3
Pakistan
3
Laos
2
Senegal
2
Burkina Faso
2
Afghanistan
2
USA
2
Haiti
2
Jordan
2
Congo, Democratic Republic of
2
Eastern Europe and Central Asia
2
South Sudan
2
Tajikistan
1
Colombia
1
Timor Leste/ East Timor
1
Benin
1
China
1
Chile
1
Cameroon
1
Iran
1
Albania
1
Kyrgyzstan
1
Guinea
1
Lithuania
1
Germany
1
Saudi Arabia
1
Western Pacific Region
1
Paraguay
1
North America
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
United Kingdom
1
Southern Africa
1
Argentina
1
Lebanon
1
Vietnam
1
Brazil
1
Moldova
1
Sri Lanka
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
362
Clinical Guidelines
49
Public Health
47
Key Resources
32
Pharmacy & Technologies
18
Women & Child Health
12
Capacity Building
6
Annual Report MEDBOX
2
Toolboxes
AMR
132
Pharmacy
86
COVID-19
70
Mental Health
43
Planetary Health
43
HIV
35
Rapid Response
31
NCDs
28
Global Health Education
28
TB
23
Caregiver
18
Conflict
18
NTDs
17
Health Financing Toolbox
17
Ebola
15
Specific Hazards
13
Refugee
4
Disability
3
Zika
3
Polio
3
Natural Hazards
2
Social Ethics
2
Cholera
1
Health Financing
1
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
The article "Time to Align: Development Cooperation for the Prevention and Control of Non-Communicable Diseases" argues for greater international cooperation and investment in addressing non-communicable diseases (NCDs), especially in low- and middle-income countries. Traditionally, global health fu...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic respiratory diseases, following the commitments made at high-level United Nations meetings. It highlights ...
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
This curriculum can be used freely in order to stimulate means of ethical analysis, reflection and decision-making.
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
The aim of the pandemic preparedness checklist is primarily to provide an outline of the essential minimum elements of preparedness, as well as elements of preparedness that are considered desirable. It is recommended that responsible authorities or institutes in countries that are in the process of...
